Depression symptoms in Alzheimer's could be signs for cognitive decline

by Massachusetts General HospitalCredit: CC0 Public DomainBOSTON -Increasingly, Alzheimer's disease (AD) research has focused on the preclinical stage, when people have biological evidence of

Updated on: April 18,2024

Depression symptoms in Alzheimer's could be signs for cognitive decline

by Massachusetts General HospitalCredit: CC0 Public DomainBOSTON -Increasingly, Alzheimer's disease (AD) research has focused on the preclinical stage, when people have biological evidence of

Updated on:April 18,2024

Approaching and avoiding 'bad' decisions are linked with different neural communication patterns

by Ingrid Fadelli , Medical XpressOverall neural network organization for avoiding decisions (A), as opposed to approaching decisions (B). These different network organizations potentially show more c

Updated on: January 11,2024

Approaching and avoiding 'bad' decisions are linked with different neural communication patterns

by Ingrid Fadelli , Medical XpressOverall neural network organization for avoiding decisions (A), as opposed to approaching decisions (B). These different network organizations potentially show more c

Updated on:January 11,2024

Your education and income level may affect your survival, recovery from stroke

byAmerican Academy of NeurologyCredit: CC0 Public DomainPeople with low education and income levels may have a 10% increased risk of death or being dependent on others to complete daily tasks th

Updated on: January 10,2024

Your education and income level may affect your survival, recovery from stroke

byAmerican Academy of NeurologyCredit: CC0 Public DomainPeople with low education and income levels may have a 10% increased risk of death or being dependent on others to complete daily tasks th

Updated on:January 10,2024

Alzheimer's breakthrough: Two short strings of amino acids could pave the way to new treatments

by Ryan O'byrne,University of AlbertaU of A neurologist Jack Jhamandas led a team that found a new treatment significantly improved memory in mice with Alzheimer's disease. The researche

Updated on: April 18,2024

Alzheimer's breakthrough: Two short strings of amino acids could pave the way to new treatments

by Ryan O'byrne,University of AlbertaU of A neurologist Jack Jhamandas led a team that found a new treatment significantly improved memory in mice with Alzheimer's disease. The researche

Updated on:April 18,2024

Digital solutions for dementia care

by Flinders UniversityFlinders University Associate Professor Kate Laver, ARC Discovery Early Career Research Fellow and occupational therapist. Credit: Flinders UniversityTelehealth delivery of

Updated on: May 09,2024

Digital solutions for dementia care

by Flinders UniversityFlinders University Associate Professor Kate Laver, ARC Discovery Early Career Research Fellow and occupational therapist. Credit: Flinders UniversityTelehealth delivery of

Updated on:May 09,2024

New research shows that the heart has a mini-brain—its own nervous system that controls the heartbeat

byKarolinska InstitutetNeuroanatomy of the adult zebrafish intracardiac nervous system. Neuroanatomy of the adult zebrafish intracardiac nervous system. Credit:Nature Communications(

Updated on: December 18,2024

New research shows that the heart has a mini-brain—its own nervous system that controls the heartbeat

byKarolinska InstitutetNeuroanatomy of the adult zebrafish intracardiac nervous system. Neuroanatomy of the adult zebrafish intracardiac nervous system. Credit:Nature Communications(

Updated on:December 18,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024

Couples and young-onset dementia: Study of coping offers hope for new interventions

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers from Massachusetts General Hospital (MGH) have used a couples-based framework to describe the experiences of individuals diag

Updated on: June 01,2024

Couples and young-onset dementia: Study of coping offers hope for new interventions

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers from Massachusetts General Hospital (MGH) have used a couples-based framework to describe the experiences of individuals diag

Updated on:June 01,2024

AI helping bring vital stroke care 'virtually to the patient's bedside'

JANUARY 19, 2024by Audrey Kirby,University of KentuckyJustin Fraser, M.D., and Muhammed Fawad Ishfaq, M.D., are able to quickly review patient scans through their phones. Credit: Lily Wilder/Uni

Updated on: March 13,2024

AI helping bring vital stroke care 'virtually to the patient's bedside'

JANUARY 19, 2024by Audrey Kirby,University of KentuckyJustin Fraser, M.D., and Muhammed Fawad Ishfaq, M.D., are able to quickly review patient scans through their phones. Credit: Lily Wilder/Uni

Updated on:March 13,2024

Brain plasticity study: Oxytocin drives development of neural connections in adult-born neurons

by Baylor College of MedicineCredit: Pixabay/CC0 Public DomainLearning a new task, mastering a musical instrument or being able to adapt to the constantly changing environment are all possible th

Updated on: February 21,2024

Brain plasticity study: Oxytocin drives development of neural connections in adult-born neurons

by Baylor College of MedicineCredit: Pixabay/CC0 Public DomainLearning a new task, mastering a musical instrument or being able to adapt to the constantly changing environment are all possible th

Updated on:February 21,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no

Updated on: April 16,2024

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no

Updated on:April 16,2024